RankingsPricing
  1. US-listed companies
  2. Merck & Co., Inc.
  3. Financials
  4. Capital expenditures

Merck & Co., Inc.MRK

Market cap
$251.9B
P/E ratio
SummaryFinancials
Period EndCapital expenditures (Million USD)YoY (%)
Dec 31, 2024-3,372-12.71%
Dec 31, 2023-3,863-11.96%
Dec 31, 2022-4,388-1.35%
Dec 31, 2021-4,448-5.04%
Dec 31, 2020-4,684+34.87%
Dec 31, 2019-3,473+32.81%
Dec 31, 2018-2,615+38.51%
Dec 31, 2017-1,888+16.98%
Dec 31, 2016-1,614+25.80%
Dec 31, 2015-1,283-2.58%
Dec 31, 2014-1,317-14.92%
Dec 31, 2013-1,548-20.78%
Dec 31, 2012-1,954+13.41%
Dec 31, 2011-1,723+2.68%
Dec 31, 2010-1,678

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)